Media Kit
Here you will find Oligomerix’s media kit, which includes videos and conference posters.
Oligomerix Corporate Backgrounder Winter 2020
“Therapeutic efficacy of a small molecule inhibitor targeting tau self-association in mouse models of tauopathy” (Poster at Clinical Trials on Alzheimer’s Disease Conference – November 2020)
Targeting tau protein with small molecule inhibitors for neurodegeneration – Video presentation by Oligomerix CMO Bill Erhardt, MD at the 21st International Conference on Alzheimer’s Drug Discovery presented by the Alzheimer’s Drug Discovery Foundation, October 2020.
Photo – James Moe, Ph.D., MBA, President and CEO
Photo – William Erhardt, M.D., Chief Medical Officer